(Q46936562)

26 December 2017

title

Unanswered questions regarding the management of sunitinib-induced hypothyroidism (English)

1 reference

26 December 2017

author name string

David Garfield

series ordinal

1

1 reference

26 December 2017

Aleck Hercbergs

series ordinal

2

1 reference

26 December 2017

Paul Davis

series ordinal

3

1 reference

26 December 2017

publication date

23 October 2007

1 reference

26 December 2017

Nature Clinical Practice Oncology

published in

1 reference

26 December 2017

volume

4

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

674

1 reference

26 December 2017

Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Imatinib induces hypothyroidism in patients receiving levothyroxine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Association between development of hypothyroidism and improved survival in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Influence of L-thyroxine administration on poor-platelet plasma VEGF concentrations in patients with induced short-term hypothyroidism, monitored for thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0998

7 January 2021

Identifiers

DOI

10.1038/NCPONC0998

1 reference

26 December 2017

1 reference

26 December 2017